13F HOLDINGS REPORT
Novo Holdings A/S
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0000950123-24-008359
Total Value
$1.72B
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BROOKFIELD CORP | 11271J107 | 3,880,230 | $161.2M | 9.36% |
| 2 | TEMPUS AI INC | TEM | 4,074,419 | $142.6M | 8.28% |
| 3 | ASML HOLDING N V | ASMLF | 133,336 | $136.4M | 7.92% |
| 4 | SALESFORCE INC | CRM | 480,160 | $123.4M | 7.17% |
| 5 | EDGEWISE THERAPEUTICS INC | EWTX | 6,344,430 | $114.3M | 6.63% |
| 6 | CORCEPT THERAPEUTICS INC | CORT | 2,411,362 | $78.3M | 4.55% |
| 7 | VAXCYTE INC | PCVX | 950,000 | $71.7M | 4.16% |
| 8 | EVOTEC AG | 30050E105 | 14,829,842 | $71.2M | 4.13% |
| 9 | EXSCIENTIA PLC | 30223G102 | 13,086,600 | $66.7M | 3.87% |
| 10 | INSMED INC | INSM | 800,000 | $53.6M | 3.11% |
| 11 | MIRUM PHARMACEUTICALS INC | MIRM | 1,500,000 | $51.3M | 2.98% |
| 12 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,000,000 | $44.8M | 2.60% |
| 13 | CABLE ONE INC | CABO | 118,403 | $41.9M | 2.43% |
| 14 | BIOMARIN PHARMACEUTICAL INC | BMRN | 490,000 | $40.3M | 2.34% |
| 15 | MERUS N V | N5749R100 | 675,000 | $39.9M | 2.32% |
| 16 | APPLE INC | AAPL | 182,960 | $38.5M | 2.24% |
| 17 | ALIBABA GROUP HLDG LTD | BBAAY | 500,827 | $36.1M | 2.09% |
| 18 | PHARVARIS N V | PHVS | 1,725,000 | $32.4M | 1.88% |
| 19 | CELLDEX THERAPEUTICS INC NEW | CLDX | 850,000 | $31.5M | 1.83% |
| 20 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 1,400,000 | $29.4M | 1.71% |
| 21 | LANZATECH GLOBAL INC | LNZAW | 15,814,845 | $29.3M | 1.70% |
| 22 | ALNYLAM PHARMACEUTICALS INC | ALNY | 118,383 | $28.8M | 1.67% |
| 23 | ARRIVENT BIOPHARMA INC | AVBP | 1,500,000 | $27.8M | 1.62% |
| 24 | MARQETA INC | MQ | 441,558 | $26.1M | 1.52% |
| 25 | CARGO THERAPEUTICS INC | 14179K101 | 1,544,000 | $25.4M | 1.47% |
| 26 | AMICUS THERAPEUTICS INC | FOLD | 2,500,000 | $24.8M | 1.44% |
| 27 | BROOKFIELD ASSET MANAGMT LTD | 113004105 | 627,207 | $23.9M | 1.39% |
| 28 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,100,000 | $23.7M | 1.37% |
| 29 | LEXEO THERAPEUTICS INC | LXEO | 1,450,500 | $23.3M | 1.35% |
| 30 | BLUEPRINT MEDICINES CORP | 09627Y109 | 175,000 | $18.9M | 1.10% |
| 31 | KYVERNA THERAPEUTICS INC | KYTX | 1,750,000 | $13.1M | 0.76% |
| 32 | MORPHIC HLDG INC | 61775R105 | 375,000 | $12.8M | 0.74% |
| 33 | VERVE THERAPEUTICS INC | 92539P101 | 2,400,000 | $11.7M | 0.68% |
| 34 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,000,000 | $9.8M | 0.57% |
| 35 | METAGENOMI INC | MGX | 1,800,000 | $7.3M | 0.43% |
| 36 | IO BIOTECH INC | IOBT | 4,429,449 | $5.2M | 0.30% |
| 37 | ABCELLERA BIOLOGICS INC | ABCL | 1,126,915 | $3.3M | 0.19% |
| 38 | GALECTO INC | 36322Q107 | 2,497,791 | $1.2M | 0.07% |
| 39 | SPERO THERAPEUTICS INC | SPRO | 468,902 | $609,573 | 0.04% |